Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
103.1 USD | +1.12% | -2.31% | +3.28% |
07:26am | China's drugmakers can't sell mRNA shots but haven't quit yet | RE |
Apr. 16 | Moderna Insider Sold Shares Worth $1,575,300, According to a Recent SEC Filing | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+3.28% | 39.05B | |
-1.08% | 41.35B | |
+41.98% | 40.38B | |
-12.11% | 26.67B | |
+2.66% | 24.07B | |
-23.60% | 18.36B | |
-2.70% | 11.68B | |
+21.79% | 11.6B | |
+8.19% | 11.15B | |
-18.53% | 9.78B |
- Stock Market
- Equities
- MRNA Stock
- News Moderna, Inc.
- Morgan Stanley Adjusts Moderna Price Target to $217 From $205, Maintains Equal Weight Rating